39L Stock Overview Operates as a pet medication and wellness company in the United States and internationally. More details
Rewards Risk Analysis See All Risk Checks Capture your thoughts, links and company narrative
Price History & Performance
Summary of share price highs, lows and changes for PetIQ Historical stock prices Current Share Price US$28.40 52 Week High US$28.60 52 Week Low US$14.20 Beta 1.74 1 Month Change 4.41% 3 Month Change 42.00% 1 Year Change 61.36% 3 Year Change 36.54% 5 Year Change 29.09% Change since IPO 42.86%
Recent News & Updates Bansk Group LLC completed the acquisition of PetIQ, Inc. (NasdaqGS:PETQ) from group of sellers.
Second quarter 2024 earnings released: EPS: US$0.52 (vs US$0.33 in 2Q 2023) Aug 08 Bansk Group LLC entered into an Agreement and Plan of Merger to acquire PetIQ, Inc. (NasdaqGS:PETQ) for approximately $980 million. Aug 07
PetIQ, Inc. to Report Q2, 2024 Results on Aug 07, 2024 Jul 18
Independent Director recently sold €248k worth of stock Jun 19
PetIQ, Inc. Provides Earnings Guidance for the Second Quarter of 2024 and Revised Earnings Guidance for the Full Year 2024 May 10 See more updates Bansk Group LLC completed the acquisition of PetIQ, Inc. (NasdaqGS:PETQ) from group of sellers.
Second quarter 2024 earnings released: EPS: US$0.52 (vs US$0.33 in 2Q 2023) Aug 08 Bansk Group LLC entered into an Agreement and Plan of Merger to acquire PetIQ, Inc. (NasdaqGS:PETQ) for approximately $980 million. Aug 07
PetIQ, Inc. to Report Q2, 2024 Results on Aug 07, 2024 Jul 18
Independent Director recently sold €248k worth of stock Jun 19
PetIQ, Inc. Provides Earnings Guidance for the Second Quarter of 2024 and Revised Earnings Guidance for the Full Year 2024 May 10
First quarter 2024 earnings released: EPS: US$0.51 (vs US$0.33 in 1Q 2023) May 09
PetIQ, Inc. to Report Q1, 2024 Results on May 08, 2024 Apr 23
PetIQ, Inc., Annual General Meeting, Jun 07, 2024 Apr 21
PetIQ, Inc. Announces Expansion of Minties Dental Treats Brand with Launch of New Dental Chew for Large-Sized Dogs Mar 15
Petiq, Inc. Provides Sales Guidance for the First Quarter and Full Year of 2024 Feb 29
Full year 2023 earnings released: EPS: US$0.073 (vs US$1.65 loss in FY 2022) Feb 29
PetIQ, Inc. to Report Q4, 2023 Results on Feb 28, 2024 Feb 08 PetIQ, Inc.'s New Sentry™? Portable Calming Diffuser Helps Calm Dogs and Cats During the Busy Holiday Season and Beyond Dec 20
Investor sentiment deteriorates as stock falls 17% Nov 15
Third quarter 2023 earnings released: EPS: US$0.015 (vs US$1.68 loss in 3Q 2022) Nov 09
Petiq, Inc. Provides Earnings Guidance for the Full Year of 2023 Nov 08
PetIQ, Inc. to Report Q3, 2023 Results on Nov 07, 2023 Oct 18
New minor risk - Share price stability Oct 01 PetIQ, Inc. Revises Earnings Guidance for the Full Year 2023
Second quarter 2023 earnings released: EPS: US$0.33 (vs US$0.16 in 2Q 2022) Aug 09
Petiq, Inc. Announces Termination of R. Michael Herrman, as Executive Vice President and Corporate Secretary Aug 05
PetIQ, Inc. to Report Q2, 2023 Results on Aug 08, 2023 Jul 23
Petiq, Inc. Provides Earnings Guidance for the Second Quarter of 2023 and Reiterates Earnings Guidance for the Full Year 2023 May 11
First quarter 2023 earnings released: EPS: US$0.33 (vs US$0.11 in 1Q 2022) May 10
Full year 2022 earnings released: US$1.65 loss per share (vs US$0.56 loss in FY 2021) Mar 02
PetIQ, Inc. to Report Q4, 2022 Results on Feb 28, 2023 Feb 01
Third quarter 2022 earnings released: US$1.68 loss per share (vs US$0.27 loss in 3Q 2021) Nov 11
PetIQ, Inc. to Report Q3, 2022 Results on Nov 09, 2022 Oct 20
President & COO recently bought €98k worth of stock Sep 08
PetIQ, Inc. (NasdaqGS:PETQ) announces an Equity Buyback for $30 million worth of its shares. Sep 07
Second quarter 2022 earnings released: EPS: US$0.16 (vs US$0.14 in 2Q 2021) Aug 11
PetIQ, Inc. Provides Sales Guidance for the Third Quarter and Full Year 2022 Aug 10
PetIQ, Inc. to Report Q2, 2022 Results on Aug 09, 2022 Jul 20
High number of new directors Jun 01
PetIQ, Inc. Appoints John Pearson as Senior Vice President, Head of Services Division May 19
PetIQ, Inc. Announces Demise of Larry Bird May 13
First quarter 2022 earnings released: EPS: US$0.11 (vs US$0.077 in 1Q 2021) May 06
High number of new directors May 05 PetIQ, Inc. Provides Revenue Guidance for the Second Quarter, First Half and Full Year 2022
PetIQ, Inc., Annual General Meeting, Jun 22, 2022 May 02
PetIQ, Inc. to Report Q1, 2022 Results on May 04, 2022 Apr 14
Full year 2021 earnings: EPS in line with analyst expectations despite revenue beat Mar 03
PetIQ, Inc. Reintroduces Sales Guidance for the First Quarter and Full Year of 2022 Mar 03
PetIQ, Inc. to Report Q4, 2021 Results on Mar 01, 2022 Feb 09
Forecast breakeven date pushed back to 2022 Dec 31
Insider recently bought €190k worth of stock Dec 17
Chairman of the Board & CEO recently bought €887k worth of stock Dec 05
Chairman of the Board & CEO recently bought €887k worth of stock Dec 03
Forecast breakeven date pushed back to 2022 Dec 02
Insider recently bought €79k worth of stock Nov 16
Third quarter 2021 earnings released: US$0.27 loss per share (vs US$2.53 loss in 3Q 2020) Nov 04
Forecast to breakeven in 2021 Nov 04
Petiq, Inc. Not Providing Earnings Guidance, Due to Uncertainty from Potential COVID-19 Aug 06
Independent Director recently sold €318k worth of stock Jun 10
Chairman of the Board & CEO recently sold €3.3m worth of stock May 27
Independent Director recently sold €710k worth of stock Mar 11
Full year 2020 earnings released: US$3.15 loss per share (vs US$0.51 loss in FY 2019) Feb 27
Revenue beats expectations Feb 27
PetIQ, Inc. Announces Board Changes, Effective march 2, 2021 Feb 25
PetIQ, Inc. to Report Q4, 2020 Results on Feb 25, 2021 Feb 12
New 90-day high: €30.80 Jan 14
New 90-day high: €29.80 Dec 30
PetIQ, Inc. Announces Resignation of James Clarke as Member of the Board of Directors, Effective December 31, 2020 Dec 24
PetIQ, Inc. Provides Update on Wellness Center Reopening Plan Sep 09
Insider recently sold €70.8k worth of stock Aug 26
First half earnings released Aug 07
PetIQ, Inc. to Report Q2, 2020 Results on Aug 06, 2020 Jul 24 Shareholder Returns 39L DE Healthcare DE Market 7D 0.7% 1.3% 2.0% 1Y 61.4% 19.9% 9.6%
See full shareholder returns
Return vs Market: 39L exceeded the German Market which returned 19.1% over the past year.
Price Volatility Is 39L's price volatile compared to industry and market? 39L volatility 39L Average Weekly Movement 13.0% Healthcare Industry Average Movement 4.8% Market Average Movement 4.9% 10% most volatile stocks in DE Market 11.7% 10% least volatile stocks in DE Market 2.4%
Stable Share Price: 39L's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: 39L's weekly volatility (13%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company Founded Employees CEO Website 2010 1,527 Cord Christensen petiq.com
PetIQ, Inc. operates as a pet medication and wellness company in the United States and internationally. It operates in two segments, Products and Services. The company offers Rx pet medications, which sells flea and tick control, heartworm preventatives, arthritis, thyroid, diabetes and pain treatments, antibiotics, and other specialty medications; and develops and manufactures its own proprietary value-branded products, as well as third-party branded products for dogs and cats.
Show more PetIQ, Inc. Fundamentals Summary How do PetIQ's earnings and revenue compare to its market cap? 39L fundamental statistics Market cap €855.76m Earnings (TTM ) €12.19m Revenue (TTM ) €1.05b
Earnings & Revenue Key profitability statistics from the latest earnings report (TTM) 39L income statement (TTM ) Revenue US$1.13b Cost of Revenue US$854.90m Gross Profit US$279.43m Other Expenses US$266.23m Earnings US$13.19m
Last Reported Earnings
Jun 30, 2024
Earnings per share (EPS) 0.44 Gross Margin 24.63% Net Profit Margin 1.16% Debt/Equity Ratio 170.0%
How did 39L perform over the long term?
See historical performance and comparison
Company Analysis and Financial Data Status Data Last Updated (UTC time) Company Analysis 2024/10/25 19:43 End of Day Share Price 2024/10/25 00:00 Earnings 2024/06/30 Annual Earnings 2023/12/31
Data Sources The data used in our company analysis is from S&P Global Market Intelligence LLC . The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package Data Timeframe Example US Source * Company Financials 10 years Income statement Cash flow statement Balance sheet Analyst Consensus Estimates +3 years Forecast financials Analyst price targets Market Prices 30 years Stock prices Dividends, Splits and Actions Ownership 10 years Top shareholders Insider trading Management 10 years Leadership team Board of directors Key Developments 10 years
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here .
Analysis Model and Snowflake Details of the analysis model used to generate this report is available on our Github page , we also have guides on how to use our reports and tutorials on Youtube .
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources PetIQ, Inc. is covered by 8 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst Institution John Lawrence Benchmark Company David Westenberg CL King & Associates, Inc. David Westenberg Guggenheim Securities, LLC
Show 5 more analysts 
